Osteoarthritis Gene Therapy Market Overview
According to the latest research by Future Market Insights, the osteoarthritis gene therapy market is expected to grow at a CAGR of 8.7%. The demand outlook is anticipated to develop steadfast during the forecast period.
The providers of this therapy are expected to go through a high demand phase that would offer them various opportunities for progress.
Get Sample Free Sample of this Premium Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14033
Osteoarthritis Gene Therapy Market Dynamics
Osteoarthritis (OA) is one of the leading cause of disability in the western world. According to the Osteoarthritis Foundation International, the prevalence of OA is approximately 500 million people, globally.
The disease is characterized by being incurable, incurring immense treatment cost but responding very poorly to the treatment. The fact that OA is a debilitating disease and gene therapy provides a hope for treatment and pain reduction, there is a very high demand for this therapy, globally. This is one of the major driver for this market.
The presence of a large number of geriatric and target patients, as well as improved healthcare infrastructure in several countries in the Asia-Pacific region, is expected to open up market opportunities during the forecast period.
Talk to Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-14033
CRISPR/Cas9 system: The latest technique in gene therapy
A novel approach to gene editing using the CRISPR / Ca9 system bypasses disease-causing mutations in a gene, providing treatment for single-gene-related genetic diseases such as cystic fibrosis, certain types of sickle cell anemia and other rare diseases.
The CRISPR / Ca9 system has created promising new therapies for genes that can target and correct disease-causing mutations in a gene. In this process, Cas9 – a bacterial protein – cuts DNA at a specific location where it can edit, trim the genetic sequence, or insert a new sequence before repairing the DNA.
Buy this Report Now: https://www.futuremarketinsights.com/checkout/14033
Key Players in the Osteoarthritis Gene Therapy Market
- Flexion
- GeneQuine
- Novartis
- Smith & Nephew
- Genascence
- Kolon TissueGene
- Sanofi
- Paraxel
- Medipost co ltd
- and Mundipharma.
The European region dominated osteoarthritis gene therapy market during the year 2020. This can be attributed to various reasons that contribute to the demand of this therapy such as rising prevalence of osteoarthritis cases in the region, increased geriatric population due to increased access to advanced medical care and rising obesity rates in various countries of Europe.
Key Segments
By Site of Injection:
- Synovium
- Cartilage
By Vectors
- Non-viral
- Retrovirus
- Lentivirus
- Adenovirus
- Adeno-associated virus (AAV)
- HSV
By End-User
- Hospitals and clinics
- Orthopedic Centers
- Assisted living Facilities
- Nursing Homes
- Ambulatory Surgical Centers
- Others
About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs